Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Intangibles (2017 - 2025)

Marimed (MRMD) has disclosed Intangibles for 9 consecutive years, with $20.7 million as the latest value for Q2 2025.

  • On a quarterly basis, Intangibles changed N/A to $20.7 million in Q2 2025 year-over-year; TTM through Jun 2025 was $20.7 million, a N/A change, with the full-year FY2024 number at $18.6 million, up 9.56% from a year prior.
  • Intangibles was $20.7 million for Q2 2025 at Marimed, down from $21.7 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $21.7 million in Q1 2025 to a low of $2.2 million in Q4 2021.
  • A 5-year average of $12.4 million and a median of $15.6 million in 2022 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: skyrocketed 713.36% in 2023, then tumbled 34.19% in 2024.
  • Marimed's Intangibles stood at $2.2 million in 2021, then soared by 536.82% to $14.2 million in 2022, then rose by 19.79% to $17.0 million in 2023, then grew by 9.56% to $18.6 million in 2024, then rose by 11.17% to $20.7 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Intangibles are $20.7 million (Q2 2025), $21.7 million (Q1 2025), and $18.6 million (Q4 2024).